drug

AZD1705

1 story · latest Aug 10, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by AstraZeneca

Timeline

Silence Therapeutics reports Q2 2026 results and divesiran trial progress

Aug 10Quarterly updateSilence Therapeutics plc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.